Sensi Seeds

DECEMBER 10, 2018

At the same time, research on medical cannabis over the past two decades has not ceased to increase and provide evidence of the plant’s medical value. As a result, medical and scientific research has been highly constrained for many decades. Exponential Increase in Cannabis Research: Trends.

Medicine 81

Medicine Research and Development Data Policy 81

The Cannigma

MARCH 2, 2021

This issue is compounded when veterans do, on rare occasions, ask their doctors about medical marijuana, only to be treated as if they are mentally unstable or receive no specific health information at all,” the researchers found. This directly conflicts with past research claiming marijuana increases PTSD symptom severity.”.

Research and Development 143

Research and Development Treatment Chronic Pain Sleep 143

Veriheal

JANUARY 16, 2024

Let’s take a closer look at this new research around CBD for Cerebral Palsy and examine the extent of this trend and its implications for the future of CP management. It occurs due to abnormalities or damage to the developing brain before, during, or after birth. Treatment plans are customized to each individual’s needs.

Patients 116

Patients CBD Treatment Therapy 116

Veriheal

AUGUST 12, 2020

Cancer is the name that has been given to a collective of related diseases which can be present in any part of the human body. Conventional and experimental treatments for cancer often involve undesired, and sometimes extreme, side effects. The Research and Testing . Background Information. What is This Modified Miracle Strain?

Strains 105

Strains Research and Development Treatment THC 105

Cannabis Law Report

SEPTEMBER 10, 2021

is a pioneering Psychedelic Healthcare Innovation & Life Sciences Company in early stage development of Psilocybin (“Magic Mushroom”) based drugs and therapies proudly announces t he Filing of U. HENDERSON, Nev. , Sept. 9, 2021 /PRNewswire/ — PsiloThera, Inc. ” The U.S.

Microdosing 98

Microdosing Research and Development Therapy Treatment 98

CannaMD

OCTOBER 6, 2020

As legalization opens new pathways for cannabis research, studies continue to expand the growing list of marijuana’s medical benefits. According to Eric Brown , lead researcher in the study at McMaster University: These findings suggest real therapeutic potential for cannabinoids as antibiotics. Is marijuana the next antibiotic?

Research and Development 116

Research and Development Marijuana Cannabinoids Conditions 116

Cannabis Law Report

JULY 21, 2021

The treatment is designed to target nociplastic pain originating in the central nervous system through the neuroplasticity benefits of psilocybin. Research Investigator, University of Michigan Department of Anesthesiology. Director of the Chronic Pain & Fatigue Research Center.

Clinical Trials 105

Clinical Trials Chronic Pain Research and Development Treatment 105

Veriheal

SEPTEMBER 30, 2021

Cannabis is an ideal substance to use during the various stages of cancer treatment but most especially after chemotherapy. Additionally, the increase in the availability of cannabis research has led to a decrease in stigmatization attached to cannabis. Pain Is a Leading Cause of Consumption.

Patients 98

Patients Research and Development Treatment Consumption 98

Cannabis Law Report

JUNE 16, 2021

Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. As two emergent complementary medicines, many parallels exist between the medical cannabis industry and the currently developing psychedelic medicine industry.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

Veriheal

FEBRUARY 9, 2023

Although many rely on imaging scans to diagnose illnesses and get treatment of various kinds, getting into the enclosed chamber can be stressful. Now, Australian researchers think they may have found an answer: taking psilocybin before MRIs. Magnetic resonance imaging (MRI) is a vital diagnostic tool in the medical world.

Clinical Trials 98

Clinical Trials Research and Development Data Collective 98

Cannabis Law Report

JULY 27, 2021

The initiative is part of Project Change Lives; Clever Leaves’ $25M product pledge to aid cannabis research in the U.S. The collaboration represents the Company’s first funded study with a research institution in the United States. organization to help advance scientific research into the potential medical benefits of cannabinoids.

Pharmaceutical 76

Pharmaceutical Research and Development Sativa Extraction 76

Cannabis Law Report

AUGUST 2, 2021

OTCQB: SPRCY ) a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, today announced positive top-line results for its proprietary compound, SCI-160 in a controlled pre-clinical trial on neuropathic and post-operative pain. TEL AVIV, Israel , Aug. ” About The Study.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

Cannabis Law Report

AUGUST 2, 2021

capital markets, negative global economic conditions, potential negative developments in our clinical trials or research programs, other negative developments in our business, or unfavorable legislative or regulatory developments. About Bionomics Limited. The post Bionomics Announces Plans to Conduct U.S.

Clinical Trials 105

Clinical Trials Research and Development Treatment Conditions 105

Cannabis Law Report

JULY 19, 2021

Philip Morris International recently offered £1 billion to buy Vectura Group PLC, the British pharmaceutical company that develops inhaled medical products. The post RYAH Group Partners with the University of Milan to Develop Conversion Measurement Standards for Dry Herb Inhalation Therapies appeared first on CannabisFN.

Therapy 76

Therapy Data Research and Development Events 76

Cannabis Law Report

JULY 8, 2021

The study is the first of its kind and will be conducted within Swinburne’s Drugs and Driving Research unit, which is led by Professor Downey. ‘We We are grateful for this grant, and especially for the opportunity to further our research in this space,’ says Professor Downey. ‘It Medicinal Cannabis Research Collaboration (MCRC).

Medicine 75

Medicine Research and Development Safety THC 75

Cannabis Law Report

JULY 19, 2021

We don’t want to see research fall to the wayside as it has for cannabis, both in Canada and globally. LMC Manna Research is also part of hyperCORE International, which has access to more than 100 award winning research sites across two continents making them the second largest clinical research site organization globally.

Clinical Trials 75

Clinical Trials Research and Development Hybrid Medicine 75

Cannabis Law Report

JUNE 30, 2021

In addition, the company aims to predict what treatments are most effective in addressing these conditions, including psychedelics, which have shown tremendous promise in early clinical trials. For example, research shows that primary care physicians misdiagnosed 65.9% MedXtractor Corp.’s of patients with social anxiety disorder.

Treatment 52

Treatment Clinical Trials Research and Development Data 52

Cannabis Law Report

JUNE 21, 2021

Pharmaceutical companies use artificial intelligence (AI) to sort through reams of scientific data to find potentially effective active ingredients to be developed into approved drugs. Over the prior three years or so, 41,260 RYAH-connected patients reported medical cannabis use for the treatment of pain. RYAH Group Inc. The Upshot.

Data 105

Data Clinical Trials Research and Development Indica 105

Cannabis Law Report

AUGUST 2, 2021

Supported by a rapidly growing body of evidence and strong FDA support, psychedelic-assisted treatments represent a paradigm shift in mental healthcare. Collectively, the team applies a diligent, in-depth scientific approach to portfolio company selection, evaluation and monitoring.

Research and Development 98

Research and Development Therapy Collective Treatment 98

Cannabis Law Report

JUNE 1, 2021

The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain. billion, servicing nearly 340,000 active patients. About RYAH Group, Inc.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

Cannabis Law Report

AUGUST 10, 2021

(“Shanti”), and all its assets focused on psychedelic MDMA-based drug development. This acquisition is focused on becoming the first and only company solving the puzzle of chronic pain with MDMA-based medicines utilizing clinical trials for the purposes of novel drug development. from 2020 to 2030 and generate revenue of $151.7

Chronic Pain 105

Chronic Pain Clinical Trials Research and Development Events 105

Cannabis Law Report

AUGUST 3, 2021

Many mental health disorders have treatment options, but they aren’t nearly as safe and efficacious as conventional pharmaceuticals or therapies. Data Bridge Market Research believes that psychedelics will grow at a 13.3% Mental health disorders are notoriously difficult to diagnose and treat. Medxtractor Corp.

Research and Development 105

Research and Development Data Conditions Therapy 105

Cannabis Law Report

SEPTEMBER 7, 2021

It has been is grown under Good Agricultural and Collection Practices (GACP), manufactured under EU Good Manufacturing Practices (EU GMP), and conforms with Therapeutic Goods (TGO 93) Order 2017. Cannabis flower is frequently prescribed as a breakthrough pain treatment or to assist with sleep, due to its rapid onset of therapeutic benefit.

Seed-To-Sale 103

Seed-To-Sale Supply Chain Research and Development Medicine 103

Puff Puff Post

MARCH 10, 2020

“We are very pleased with the rapid completion of enrollment achieved by the team at the Centre for Human Drug Research (CHDR) in Leiden, the Netherlands,” said Alexandra Mancini, InMed’s Senior Vice President of Clinical Development & Regulatory Affairs. Visit [link].

Clinical Trials 84

Clinical Trials Pharmaceutical Research and Development Cannabinoids 84

United Patients Group

JANUARY 19, 2023

Researchers are interested in studying the gut-brain connection. It has been shown that the gut microbiome (the collection of bacteria in our digestive systems) plays an important role in both mental and physical health, potentially influencing behavior and learning ability in children with autism spectrum disorder (ASD).

Digestion 105

Digestion Research and Development Sleep Food 105

Veriheal

JULY 23, 2020

According to the Oregon Cannabis Association (OCA) , police budgets received more than $2 million directly from cannabis tax proceeds last year – despite the city passing a measure in 2016 stipulating that those funds should be designated for substance misuse treatment, public safety, and small business development.

Research and Development 98

Research and Development Safety Treatment Cannabis 98

Cannabis Law Report

JANUARY 31, 2022

TSX-V:NUMI, OTC:LKYSF) said that its research facility– Numinus Bioscience– has been included on Health Canada’s list of federally licensed psilocybin producers. This list is available by request to those seeking access to psilocybin through the Special Access Program (SAP), and clinical researchers. Numinus Wellness Inc.

Research and Development 52

Research and Development Clinical Trials Packaging Access 52

Cannabis Law Report

MARCH 6, 2019

I recently had the unbelievably good fortune to be a participant, attendee and a featured speaker at the Global Cannabis Business Development Conference held in Portland, Oregon last week. The collective IQ in that room was staggering! PUBLISHER: CANNABIS LAW REPORT. When they said “global”, boy did they mean it.

Business 51

Business Research and Development Treatment Collective 51

Veriheal

JUNE 30, 2023

A study investigated psilocybin’s effect on alcohol addiction, the FDA outlined best practices for future psychedelic research, and the NCAA is inching toward cannabis policy change. For their analysis, researchers conducted qualitative interviews with 13 individuals who had participated in a psilocybin clinical trial.

Clinical Trials 98

Clinical Trials Research and Development Therapy Policy 98

The Herb Collective

AUGUST 1, 2023

Reduces Anxiety and Depression: For those dealing with anxiety and depression, finding an effective treatment can be a daunting task. While the exact mechanisms behind this phenomenon are still being researched, the results are promising.

Indica 87

Indica Blood Pressure Epilepsy Sleep 87

Veriheal

FEBRUARY 18, 2021

But it’s acknowledged that it transpires because of the current illicit status, which we strive to change by advocating for research, legal access, and responsible consumption. The university has conducted research that studied the best music to include in psychedelic therapy. Johns Hopkins Explored Which Music Genres Work Best.

Therapy 52

Therapy Research and Development Collective Consumption 52

Greencamp

FEBRUARY 17, 2019

The science and research behind cannabis and IBS has linked the imbalances of our endocannabinoid system with certain IBS symptoms. Irritable bowel syndrome (IBS) is a collection of symptoms which create discomfort in the abdominal area, resulting in the inflammation of the digestive tract. Research on cannabis and IBS.

Digestion 96

Digestion Research and Development Marijuana Cannabinoids 96

Cannabis Law Report

DECEMBER 9, 2021

The study flagship site will be at John Hopkins University (JHU) with research led by Dr. Matthew Johnson. The study involved 100 treatment-resistant patients and were randomized to psilocybin or the nicotine patch, each receiving the same cognitive-behavioral therapy. DENVER, Dec.

Clinical Trials 52

Clinical Trials Research and Development Therapy Treatment 52

Veriheal

AUGUST 24, 2022

Activists collected over 100,000 more signatures than needed to qualify the measure for the ballot, showing significant support for its passing. In May 2022, Connecticut’s governor signed a budget bill that included a provision for the implementation of psychedelic-assisted therapy treatment centers.

Legalization 111

Legalization Decriminalization Medicine Research and Development 111

Greencamp

OCTOBER 3, 2018

People develop PTSD after experiencing a traumatic event or an event that is perceived as such. Some people manage to naturally leave that memory where it belongs (in the past) but others develop flashbacks which then awaken the same emotional response. Does clinical research support the use of cannabis for PTSD?

Research and Development 111

Research and Development Terpenes Events Strains 111

Cannabis Law Report

JULY 7, 2021

is a company focused on consolidating medical clinics and becoming a North American leader in mental health treatments. It is working to provide the critical infrastructure needed to develop and deliver breakthrough mental health treatments. KetamineOne Capital Limited (formerly Myconic Capital Corp.)

Research and Development 98

Research and Development Treatment Therapy Banking 98

Cannabis Law Report

MARCH 3, 2020

Now, he is the Vice-Chair of Indiana NORML — an organization who is currently focused on changing cannabis laws for the access to Medical Cannabis as therapeutic treatment in Indiana. Current federal regulations impede the research necessary to evaluate and determine the therapeutic use of marijuana and related cannabinoids. .

Policy 81

Policy Research and Development Chronic Pain Cannabinoids 81